Synjardy XR 1000 mg/1

Synjardy XR 1000 mg/1 combines empagliflozin and metformin hydrochloride for blood sugar management. This extended-release tablet is designed for oral use and is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.

Synjardy XR 1000 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes. The combination of empagliflozin and metformin hydrochloride works to improve glycemic control. This medication is typically used as part of a broader treatment plan that includes diet and exercise. It is important to consult with a healthcare provider to determine if Synjardy XR 1000 mg/1 is suitable for your specific needs.

Common effects of Synjardy XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may also experience urinary tract infections or genital mycotic infections. These effects can vary from person to person, and it is important to monitor any changes in your health while taking this medication.

Synjardy XR 1000 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Synjardy XR 1000 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of side effects.